Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB.

Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB. — المؤلف: Liu, Pingping — Pathology oncology research : POR 20220517

المؤلف
Liu, Pingping
النشر
Pathology oncology research : POR 20220517
الوصف
1610294 p.
الموضوعات
Female؛ Humans؛ Inflammation؛ Neoadjuvant Therapy؛ Prognosis؛ Retrospective Studies؛ Uterine Cervical Neoplasms